Concurrent Chemoradiation + 5-FU + Mitomycin-C in Anal Carcinoma

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

July 31, 2017

Study Completion Date

November 30, 2021

Conditions

Carcinoma of the Anal Canal

Interventions

RADIATION

Pencil Beam scanning Radiation

DRUG

5-fluorouracil

DRUG

Mitomycin-C

Trial Locations (2)

Roberts Proton Therapy Center of the University of Pennsylvania, Philadelphia

Massachusetts General Hospital, Boston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Massachusetts General Hospital

OTHER

NCT01858025 - Concurrent Chemoradiation + 5-FU + Mitomycin-C in Anal Carcinoma | Biotech Hunter | Biotech Hunter